Stroke Prevention

• Population-based assessment of stroke risk factors
  • Northern Manhattan Study: Mitchell Elkind, Joshua Willey, Jose Gutierrez
  • Cardiovascular Health Study: Mitchell Elkind, Joshua Willey, Jose Gutierrez
  • California Teachers Study: Mitchell Elkind, Jose Gutierrez
• Stroke, Frailty and Successful Aging: Joshua Willey
• Hip-Hop Public Health: utilizing youth in stroke care in the community: Olajide Williams
• Engaging Religious Institutions for Dissemination of Stroke Information in the Community: Olajide Williams
• Practice-based trial of home BP telemonitoring among minority stroke survivors: Olajide Williams
• Antiplatelet versus anticoagulation for stroke prevention in patients with cancer: Randolph Marshall
• Follow-up for the medical arm of the unruptured brain arteriovenous population from the ARUBA trial: JP Mohr
• Stroke in left ventricular assist devices: Joshua Willey
• AtRial Cardiopathy and Antithrombotic Drugs In prevention After cryptogenic stroke (ARCADIA): Mitchell Elkind

Stroke Pathophysiology

• Blood Flow and Cognition: the impact of cerebral hemodynamics on cognitive function in carotid artery disease: Randolph Marshall
• Vascular remodeling, a pathological study of the development of atherosclerosis and dolichoectasia: Jose Gutierrez
• HIV infection and stroke: Jose Gutierrez
• The impact of cardiac disease on cognitive dysfunction: MaryKay Pavol
• Genetics control of the Blood Brain Barrier in ischemia: Dritan Agalliu
• Genetics of collateral formation in acute ischemia: Randolph Marshall
• Risk of Paradoxical Embolism (RoPE) Study: Mitchell Elkind
• Vertebrobasilar Flow Evaluation and Risk of Transient Ischemic Attack & Stroke (VERITAS): Mitchell Elkind
• Traffic pollution and cerebrovascular disease in the Northern Manhattan Study: Mitchell Elkind
• Vasculopathy and Infection in Pediatric Stroke: Mitchell Elkind
• Mechanisms of Early Recurrence in Intracranial Atherosclerotic Disease (MyRIAD): Mitchell Elkind

Stroke Recovery

• The effect of a novel pharmacological agent on neuroplasticity after stroke: Randolph Marshall
• Application of procedural Memory Strategies to Rehabilitation (MAStR): MaryKay Pavol
• Follow-up for the interventional arm of the unruptured brain arteriovenous population from the ARUBA trial: JP Mohr

Acute Stroke Clinical Trials

• High dose statins for neuroprotection in acute stroke: Mitchell Elkind
• Sliding scale versus standard administration of insulin in acute stroke: Neuro-ICU collaboration with Jan Claassen
• Aspirin monotherapy versus Aspirin and Clopidogrel for minor stroke and TIA (POINT trial): Joshua Willey
• Aspirin versus Ticagrelor for minor stroke and TIA (SOCRATES trial): Joshua Willey
• Tissue plasminogen activator for minor stroke (PRISMS trial): Joshua Willey
• Hypothermia for Neuroprotection in acute stroke: Neuro-ICU collaboration with Jan Claassen
• Desferoxamine for treatment of Intracranial Hemorrhage: Neuro-ICU collaboration with Jan Claassen
• Intravenous Natalizumab for Reducing Infarct Volume in Acute Ischemic Stroke (ACTION): Mitchell Elkind

Outcomes Research

• Healthcare Cost Utilization Project Analyses: Mitchell Elkind
• Get With The Guidelines – STROKE: Joshua Willey
• SPARCS (HOSPTALIZATIONS IN New York STATE): Joshua Willey, Mitchell Elkind
• National Health and Nutrition Examination Survey (NHANES): Jose Gutierrez
• Outcome predictors after cardiac arrest: Sachin Agarwal
• Modeling hemorrhage risk for brain vascular anomalies: retrospective comparison of annual hemorrhage rates for brain arteriovenous malformations and cavernous angiomas: JP Mohr